MALARIA (PLASMODIUM FALCIPARUM)
Clinical trials for MALARIA (PLASMODIUM FALCIPARUM) explained in plain language.
Never miss a new study
Get alerted when new MALARIA (PLASMODIUM FALCIPARUM) trials appear
Sign up with your email to follow new studies for MALARIA (PLASMODIUM FALCIPARUM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Malaria vaccine booster trial aims to keep school kids protected
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a booster dose of the R21/Matrix-M malaria vaccine in 30-40 school children in Burkina Faso who already received four doses years earlier. Researchers want to see if a booster is safe and how well it boosts immunity, comparing two different doses. The goal is to …
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:55 UTC
-
Could a cancer drug help beat malaria? new trial aims to stop drug-resistant parasites
Disease control Recruiting nowThis study tests whether adding imatinib (a cancer drug) to the standard malaria treatment can clear the parasite faster and prevent drug resistance. About 1,100 adults with mild to moderate malaria will receive either the standard 3-day treatment or a shorter 2-day combo. The go…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE2 • Sponsor: Victoria Biomedical Research Institute • Aim: Disease control
Last updated May 26, 2026 03:57 UTC